After-Hours Stock Movers: IVERIC bio,Apellis Pharmaceuticals,Affirm and more_老虎社区_美港股上老虎

After-Hours Stock Movers: IVERIC bio,Apellis Pharmaceuticals,Affirm and more

StreetInsider2021-09-10

After-Hours Stock Movers: IVERIC bio (NASDAQ: ISEE) 47.9% HIGHER; gains following data from Apellis Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) 31.9% LOWER; reported top-line results from the Phase 3...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

249

HENRYCSC
·2021-09-10
👌
回复
点赞
举报
SanWangtikup
·2021-09-10
Like pls
回复
1
举报
小虎一飞冲天
·2021-09-10
Like pls. Thanks.
回复
1
举报
五个老乡
·2021-09-10
`@挚文集团
回复
点赞
举报
Mhong
·2021-09-10
Like & comment
回复
3
举报
收起
- kenong62:
  done
  2021-09-10
  回复
  举报
Ahlec
·2021-09-10
Sold my affirm early [流泪]
回复
2
举报
Nez
·2021-09-10
Ok noted
回复
3
举报
收起
- Nez:
  True that
  2021-09-10
  回复
  举报
- Bryonie:
  Now is too pricey to enter
  2021-09-10
  回复
  举报
JoelLee
·2021-09-10
Reply and comment pls thx!
回复
6
举报
收起
- Nez:
  Pls like and comment too thanks
  2021-09-10
  回复
  举报
- Ahlec:
  ment
  2021-09-10
  回复
  举报
- tan0524u:
  Great
  2021-09-10
  回复
  举报
KongSH
·2021-09-10
周末来临前，祝愿大家今天再发一笔😄😄
回复
6
举报
收起
- ming22:
  [鼓掌]
  2021-09-10
  回复
  举报
A68
·2021-09-10
OK
回复
6
举报
jayfalcon
·2021-09-10
Interesting to know [哇塞]
回复
5
举报
winterflower
·2021-09-10
Please like thank you
回复
4
举报
FrederickL
·2021-09-10
Wow. Like!
回复
5
举报
收起
- OinKeY:
  Yea man!!!
  2021-09-10
  回复
  举报
Yuyu1988
·2021-09-10
Please like. Thanks.
回复
7
举报
收起
- Chris82:
  Liked
  2021-09-10
  回复
  举报
- Nez:
  Done pls like and comment too thanks
  2021-09-10
  回复
  举报
牛劲十足
·2021-09-10
Like
回复
6
举报
Bonds
·2021-09-10
Up and up
回复
4
举报
收起
- 牛劲十足:
  YEs
  2021-09-10
  回复
  举报
KLCC
·2021-09-10
Liked
回复
4
举报
收起
- Irenelim85:
  🦾
  2021-09-10
  回复
  举报
Goodmeng
·2021-09-10
Good
回复
6
举报
Desoupie
·2021-09-10
Like pls [Bless]
回复
6
举报
收起
- Kinokinok:
  ok
  2021-09-10
  回复
  举报
saral
·2021-09-10
Like pls thks.
回复
4
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2166479623?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-09-10 07:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2166479623","market":"us","top_or_hot":-1,"title":"After-Hours Stock Movers: IVERIC bio,Apellis Pharmaceuticals,Affirm and more","media":"StreetInsider","content":"<div>\n<p>After-Hours Stock Movers:\nIVERIC bio (NASDAQ: ISEE) 47.9% HIGHER; gains following data from Apellis\nApellis Pharmaceuticals, Inc. (Nasdaq: APLS) 31.9% LOWER; reported top-line results from the Phase 3...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18924599\">网页链接</a>\n\n</div>\n","source":"highlight_streetinsider","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: IVERIC bio,Apellis Pharmaceuticals,Affirm and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: IVERIC bio,Apellis Pharmaceuticals,Affirm and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-10 07:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18924599><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nIVERIC bio (NASDAQ: ISEE) 47.9% HIGHER; gains following data from Apellis\nApellis Pharmaceuticals, Inc. (Nasdaq: APLS) 31.9% LOWER; reported top-line results from the Phase 3...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18924599\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"APLS","symbol_name":"Apellis Pharmaceuticals Inc.","start_time":0,"source_url":"https://www.streetinsider.com/dr/news.php?id=18924599","article_id":"2166479623","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2166479623","pubTimestamp":1631231042,"sourceInfo":{"source_id":"highlight_streetinsider","name":"StreetInsider"},"weMediaInfo":null,"summary":"After-Hours Stock Movers:\nIVERIC bio (NASDAQ: ISEE) 47.9% HIGHER; gains following data from Apellis\n","collect":0,"end_time":0,"defaultTopTitle":"streetinsider.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"APLS":"Apellis Pharmaceuticals Inc.","ZUMZ":"Zumiez Inc","ISEE":"IVERIC bio Inc","AFRM":"Affirm Holdings, Inc.","KPLT":"Katapult Holdings, Inc.","COOK":"Traeger Inc. (TGPX Holdings I LLC)"},"translate_title":"盘后股票市场：IVERIC bio、Apellis Pharmaceuticals、Affirm等","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AFRM":0.9,"APLS":0.9,"COOK":0.9,"ISEE":0.9,"KPLT":0.9,"ZUMZ":0.9},"content_text":"After-Hours Stock Movers:\nIVERIC bio (NASDAQ: ISEE) 47.9% HIGHER; gains following data from Apellis\nApellis Pharmaceuticals, Inc. (Nasdaq: APLS) 31.9% LOWER; reported top-line results from the Phase 3 DERBY and OAKS studies evaluating intravitreal pegcetacoplan, an investigational targeted C3 therapy, in 1,258 adults with geographic atrophy (GA) secondary to age-related macular degeneration (AMD). OAKS met the primary endpoint for both monthly and every-other-month treatment with pegcetacoplan, demonstrating a significant reduction in GA lesion growth of 22% (p=0.0003) and 16% (p=0.0052), respectively, compared to pooled sham at 12 months. DERBY did not meet the primary endpoint of GA lesion growth, showing a reduction of 12% (p=0.0528) and 11% (p=0.0750) with monthly and every-other-month treatment, respectively, compared to pooled sham at 12 months.\nAffirm Holdings, Inc. (NASDAQ: AFRM) 20.8% HIGHER; reported Q4 EPS of ($0.48), $0.19 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $261.8 million versus the consensus estimate of $225.29 million. Affirm Holdings, Inc. sees Q1 2022 revenue of $240-250 million, versus the consensus of $233.9 million. Affirm Holdings, Inc. sees FY2022 revenue of $1.16-1.19 billion, versus the consensus of $1.17 billion.\nKatapult Holdings, Inc. (NASDAQ: KPLT) 12.2% HIGHER; gains on AFRM results.\nTraeger, Inc. (NYSE: COOK) 9.8% LOWER; reported Q2 EPS of ($0.05), versus $0.17 reported last year. Revenue for the quarter came in at $213 million, versus $153.2 million reported last year. Traeger, Inc. sees FY2021 revenue of $760-770 million. Adjusted EBITDA is expected to be between $103 million and $108 million\nCedar Realty Trust (NYSE: CDR) 8.5% HIGHER; announced that its Board of Directors has initiated a dual-track process to review the Company's strategic alternatives in order to maximize shareholder value. As part of this process, Cedar is exploring, among other alternatives, a potential sale or merger involving the entire Company, and alternatively the potential sale of its core grocery-anchored shopping center portfolio and its mixed-use redevelopment projects.\nAmerican Outdoor Brands (NASDAQ: AOUT) 5.9% HIGHER; reported Q1 EPS of $0.48, $0.08 better than the analyst estimate of $0.40. Revenue for the quarter came in at $60.8 million versus the consensus estimate of $57.35 million. American Outdoor Brands sees FY2022 EPS of $2.02-$2.26, versus the consensus of $2.21. American Outdoor Brands sees FY2022 revenue of $280-295 million, versus the consensus of $291 million.\nSumo Logic Inc. (NASDAQ: SUMO) 6.3% LOWER; reported Q2 EPS of ($0.11), $0.03 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $58.8 million versus the consensus estimate of $56.69 million. Sumo Logic Inc. sees Q3 2022 EPS of ($0.14), versus the consensus of ($0.15). Sumo Logic Inc. sees Q3 2022 revenue of $60.3-61.3 million, versus the consensus of $60.05 million. Sumo Logic Inc. sees FY2022 EPS of ($0.52)-($0.51), versus the consensus of ($0.56). Sumo Logic Inc. sees FY2022 revenue of $236.8-238.8 million, versus the consensus of $235.02 million\nCano Health (NYSE: CANO) 2.2% HIGHER; Cowen initiates coverage with an Outperform rating and a price target of $18.00.\nZumiez, Inc. (NASDAQ: ZUMZ) 5.3% LOWER; reported Q2 EPS of $0.94, $0.16 better than the analyst estimate of $0.78. Revenue for the quarter came in at $268.7 million versus the consensus estimate of $279.79 million.\nClover Health (NASDAQ: CLOV) 2.6% LOWER; Cowen analyst Gary Taylor initiates coverage with an Underperform rating and a price target of $7.00.\nEditas Medicine (NASDAQ: EDIT) 2.2% HIGHER; Oppenheimer upgraded from Perform to Outperform with a price target of $80.00 (from $42.00).\nTake-Two Interactive Software, Inc. (NASDAQ: TTWO) 2.5% LOWER; reiterated its outlook for its fiscal year 2022, ending March 31, 2022, which was originally provided on May 18, 2021 and reiterated on August 2, 2021. The Company’s wholly-owned label, Rockstar Games, has announced that the expanded and enhanced versions of Grand Theft Auto V and Grand Theft Auto Online for PlayStation 5 and Xbox Series X|S, which had been planned for release on November 11, 2021, are now planned to launch in March 2022 to allow additional time to further polish the final products.\nZscaler (NASDAQ: ZS) 2.4% HIGHER; reported Q4 EPS of $0.14, $0.05 better than the analyst estimate of $0.09. Revenue for the quarter came in at $197.1 million versus the consensus estimate of $186.82 million. Zscaler sees Q1 2022 EPS of $0.12, versus the consensus of $0.12. Zscaler sees Q1 2022 revenue of $210-212 million, versus the consensus of $199.7 million. Zscaler sees FY2022 EPS of $0.52-$0.56, versus the consensus of $0.56. Zscaler sees FY2022 revenue of $940-950 million, versus the consensus of $905.8 million.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":883240888,"gmtCreate":1631247875644,"gmtModify":1632883650960,"author":{"id":"3575091428590185","authorId":"3575091428590185","name":"HENRYCSC","avatar":"https://static.tigerbbs.com/6d47a6dec25b21dc547a5b982674c499","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"👌&nbsp;","listText":"👌&nbsp;","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883240888","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":883253116,"gmtCreate":1631247094735,"gmtModify":1632883655835,"author":{"id":"4087452914358580","authorId":"4087452914358580","name":"SanWangtikup","avatar":"https://static.tigerbbs.com/c7f061d50a9f915d0ce8e8c879871960","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883253116","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":883259145,"gmtCreate":1631246952987,"gmtModify":1631889604508,"author":{"id":"3582098623642517","authorId":"3582098623642517","name":"小虎一飞冲天","avatar":"https://static.tigerbbs.com/1a55a61195830e019abf5d3cc69681b9","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Like pls. Thanks.","listText":"Like pls. Thanks.","text":"Like pls. Thanks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883259145","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":883266257,"gmtCreate":1631245242179,"gmtModify":1631249668928,"author":{"id":"3576259559844048","authorId":"3576259559844048","name":"五个老乡","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"`<a href=\"https://laohu8.com/U/4093065077764910\">@挚文集团</a>","listText":"`<a href=\"https://laohu8.com/U/4093065077764910\">@挚文集团</a>","text":"`@挚文集团","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883266257","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":883236838,"gmtCreate":1631242300024,"gmtModify":1631887814745,"author":{"id":"3578449123371823","authorId":"3578449123371823","name":"Mhong","avatar":"https://static.tigerbbs.com/f1110c90505cf18cc129130892c4dc2a","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like &amp; comment","listText":"Like &amp; comment","text":"Like & comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/883236838","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5814584,"gmtCreate":1631242411263,"gmtModify":1631887814748,"authorId":3574928367638029,"author":{"id":3574928367638029,"authorId":3574928367638029,"name":"kenong62","avatar":"https://static.tigerbbs.com/37fd00bd8cea11b8aa1aed6d9ddd9413","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883236838,"type":1,"supId":0,"prevId":0,"content":"done","text":"done","html":"done"}],"langContent":"EN"},{"id":883207595,"gmtCreate":1631241291417,"gmtModify":1631885117638,"author":{"id":"4091753544363040","authorId":"4091753544363040","name":"Ahlec","avatar":"https://static.tigerbbs.com/81afb03fdd19de870e28208208ff7909","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Sold my affirm early&nbsp;[流泪]&nbsp;","listText":"Sold my affirm early&nbsp;[流泪]&nbsp;","text":"Sold my affirm early [流泪]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883207595","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":883646704,"gmtCreate":1631239934108,"gmtModify":1631892244278,"author":{"id":"3577664011514694","authorId":"3577664011514694","name":"Nez","avatar":"https://static.tigerbbs.com/b32d6842fa474340581d116936497abb","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Ok noted","listText":"Ok noted","text":"Ok noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/883646704","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5815746,"gmtCreate":1631248240989,"gmtModify":1631892244289,"authorId":3577664011514694,"author":{"id":3577664011514694,"authorId":3577664011514694,"name":"Nez","avatar":"https://static.tigerbbs.com/b32d6842fa474340581d116936497abb","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883646704,"type":1,"supId":5815617,"prevId":0,"content":"True that","text":"True that","html":"True that"},{"id":5815617,"gmtCreate":1631247295862,"gmtModify":1631892244277,"authorId":3586074983708406,"author":{"id":3586074983708406,"authorId":3586074983708406,"name":"Bryonie","avatar":"https://static.tigerbbs.com/40e9091aa418c1a4602b3db85fa8cf56","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883646704,"type":1,"supId":0,"prevId":0,"content":"Now is too pricey to <u>enter</u>","text":"Now is too pricey to <u>enter</u>","html":"Now is too pricey to <u>enter</u>"}],"langContent":"EN"},{"id":883625425,"gmtCreate":1631239048467,"gmtModify":1632883719022,"author":{"id":"3579882572140125","authorId":"3579882572140125","name":"JoelLee","avatar":"https://static.tigerbbs.com/e1f6c92b13d94cba61906c07dbbb2ab6","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Reply and comment pls thx!","listText":"Reply and comment pls thx!","text":"Reply and comment pls thx!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/883625425","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5813996,"gmtCreate":1631239948702,"gmtModify":1634803750377,"authorId":3577664011514694,"author":{"id":3577664011514694,"authorId":3577664011514694,"name":"Nez","avatar":"https://static.tigerbbs.com/b32d6842fa474340581d116936497abb","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883625425,"type":1,"supId":0,"prevId":0,"content":"Pls like and comment too thanks","text":"Pls like and comment too thanks","html":"Pls like and comment too thanks"},{"id":5814315,"gmtCreate":1631241308956,"gmtModify":1634803725952,"authorId":4091753544363040,"author":{"id":4091753544363040,"authorId":4091753544363040,"name":"Ahlec","avatar":"https://static.tigerbbs.com/81afb03fdd19de870e28208208ff7909","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883625425,"type":1,"supId":0,"prevId":0,"content":"<u>ment</u>","text":"<u>ment</u>","html":"<u>ment</u>"},{"id":5814398,"gmtCreate":1631241736999,"gmtModify":1634803721377,"authorId":3567505470517950,"author":{"id":3567505470517950,"authorId":3567505470517950,"name":"tan0524u","avatar":"https://static.tigerbbs.com/36ccaf6467346df7588feaddbaa96926","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883625425,"type":1,"supId":0,"prevId":0,"content":"Great","text":"Great","html":"Great"}],"langContent":"EN"},{"id":883669489,"gmtCreate":1631238288441,"gmtModify":1631889402166,"author":{"id":"4091169623174150","authorId":"4091169623174150","name":"KongSH","avatar":"https://static.tigerbbs.com/4db5a338d9f077992726659f508a7685","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"周末来临前，祝愿大家今天再发一笔😄😄","listText":"周末来临前，祝愿大家今天再发一笔😄😄","text":"周末来临前，祝愿大家今天再发一笔😄😄","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/883669489","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5813635,"gmtCreate":1631238823830,"gmtModify":1631889402166,"authorId":3571044771112848,"author":{"id":3571044771112848,"authorId":3571044771112848,"name":"ming22","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883669489,"type":1,"supId":0,"prevId":0,"content":"[鼓掌]","text":"[鼓掌]","html":"[鼓掌]"}],"langContent":"CN"},{"id":883612617,"gmtCreate":1631237579939,"gmtModify":1631890380544,"author":{"id":"3576813955258325","authorId":"3576813955258325","name":"A68","avatar":"https://static.tigerbbs.com/d209afa981c29a4dc34bd7c1c986fb4a","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"OK","listText":"OK","text":"OK","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883612617","repostId":2166479623,"repostType":4,"repost":{"id":"2166479623","pubTimestamp":1631231042,"share":"https://www.laohu8.com/m/news/2166479623?lang=&edition=full","pubTime":"2021-09-10 07:44","market":"us","language":"en","title":"After-Hours Stock Movers: IVERIC bio,Apellis Pharmaceuticals,Affirm and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2166479623","media":"StreetInsider","summary":"After-Hours Stock Movers:\nIVERIC bio (NASDAQ: ISEE) 47.9% HIGHER; gains following data from Apellis\n","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ISEE\">IVERIC bio</a> (NASDAQ: ISEE) 47.9% HIGHER; gains following data from Apellis</p>\n<p><a href=\"https://laohu8.com/S/APLS\">Apellis Pharmaceuticals, Inc.</a> (Nasdaq: APLS) 31.9% LOWER; reported top-line results from the Phase 3 DERBY and OAKS studies evaluating intravitreal pegcetacoplan, an investigational targeted C3 therapy, in 1,258 adults with geographic atrophy (GA) secondary to age-related macular degeneration (<a href=\"https://laohu8.com/S/AMD\">AMD</a>). OAKS met the primary endpoint for both monthly and every-other-month treatment with pegcetacoplan, demonstrating a significant reduction in GA lesion growth of 22% (p=0.0003) and 16% (p=0.0052), respectively, compared to pooled sham at 12 months. DERBY did not meet the primary endpoint of GA lesion growth, showing a reduction of 12% (p=0.0528) and 11% (p=0.0750) with monthly and every-other-month treatment, respectively, compared to pooled sham at 12 months.</p>\n<p><a href=\"https://laohu8.com/S/AFRM\">Affirm Holdings, Inc.</a> (NASDAQ: AFRM) 20.8% HIGHER; reported Q4 EPS of ($0.48), $0.19 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $261.8 million versus the consensus estimate of $225.29 million. Affirm Holdings, Inc. sees Q1 2022 revenue of $240-250 million, versus the consensus of $233.9 million. Affirm Holdings, Inc. sees FY2022 revenue of $1.16-1.19 billion, versus the consensus of $1.17 billion.</p>\n<p><a href=\"https://laohu8.com/S/KPLT\">Katapult Holdings, Inc.</a> (NASDAQ: KPLT) 12.2% HIGHER; gains on AFRM results.</p>\n<p><a href=\"https://laohu8.com/S/COOK\">Traeger, Inc.</a> (NYSE: COOK) 9.8% LOWER; reported Q2 EPS of ($0.05), versus $0.17 reported last year. Revenue for the quarter came in at $213 million, versus $153.2 million reported last year. Traeger, Inc. sees FY2021 revenue of $760-770 million. Adjusted EBITDA is expected to be between $103 million and $108 million</p>\n<p><a href=\"https://laohu8.com/S/CDR\">Cedar Realty Trust</a> (NYSE: CDR) 8.5% HIGHER; announced that its Board of Directors has initiated a dual-track process to review the Company's strategic alternatives in order to maximize shareholder value. As part of this process, Cedar is exploring, among other alternatives, a potential sale or merger involving the entire Company, and alternatively the potential sale of its core grocery-anchored shopping center portfolio and its mixed-use redevelopment projects.</p>\n<p><a href=\"https://laohu8.com/S/AOUT\">American Outdoor Brands</a> (NASDAQ: AOUT) 5.9% HIGHER; reported Q1 EPS of $0.48, $0.08 better than the analyst estimate of $0.40. Revenue for the quarter came in at $60.8 million versus the consensus estimate of $57.35 million. American Outdoor Brands sees FY2022 EPS of $2.02-$2.26, versus the consensus of $2.21. American Outdoor Brands sees FY2022 revenue of $280-295 million, versus the consensus of $291 million.</p>\n<p><a href=\"https://laohu8.com/S/SUMO\">Sumo Logic Inc.</a> (NASDAQ: SUMO) 6.3% LOWER; reported Q2 EPS of ($0.11), $0.03 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $58.8 million versus the consensus estimate of $56.69 million. Sumo Logic Inc. sees Q3 2022 EPS of ($0.14), versus the consensus of ($0.15). Sumo Logic Inc. sees Q3 2022 revenue of $60.3-61.3 million, versus the consensus of $60.05 million. Sumo Logic Inc. sees FY2022 EPS of ($0.52)-($0.51), versus the consensus of ($0.56). Sumo Logic Inc. sees FY2022 revenue of $236.8-238.8 million, versus the consensus of $235.02 million</p>\n<p><a href=\"https://laohu8.com/S/CANO\">Cano Health</a> (NYSE: CANO) 2.2% HIGHER; Cowen initiates coverage with an Outperform rating and a price target of $18.00.</p>\n<p><a href=\"https://laohu8.com/S/ZUMZ\">Zumiez, Inc.</a> (NASDAQ: ZUMZ) 5.3% LOWER; reported Q2 EPS of $0.94, $0.16 better than the analyst estimate of $0.78. Revenue for the quarter came in at $268.7 million versus the consensus estimate of $279.79 million.</p>\n<p><a href=\"https://laohu8.com/S/CLOV\">Clover Health</a> (NASDAQ: CLOV) 2.6% LOWER; Cowen analyst Gary Taylor initiates coverage with an Underperform rating and a price target of $7.00.</p>\n<p><a href=\"https://laohu8.com/S/EDIT\">Editas Medicine</a> (NASDAQ: EDIT) 2.2% HIGHER; Oppenheimer upgraded from Perform to Outperform with a price target of $80.00 (from $42.00).</p>\n<p><a href=\"https://laohu8.com/S/TTWO\">Take-Two Interactive Software</a>, Inc. (NASDAQ: TTWO) 2.5% LOWER; reiterated its outlook for its fiscal year 2022, ending March 31, 2022, which was originally provided on May 18, 2021 and reiterated on August 2, 2021. The Company’s wholly-owned label, Rockstar Games, has announced that the expanded and enhanced versions of Grand Theft Auto V and Grand Theft Auto Online for PlayStation 5 and Xbox Series X|S, which had been planned for release on November 11, 2021, are now planned to launch in March 2022 to allow additional time to further polish the final products.</p>\n<p><a href=\"https://laohu8.com/S/ZS\">Zscaler</a> (NASDAQ: ZS) 2.4% HIGHER; reported Q4 EPS of $0.14, $0.05 better than the analyst estimate of $0.09. Revenue for the quarter came in at $197.1 million versus the consensus estimate of $186.82 million. Zscaler sees Q1 2022 EPS of $0.12, versus the consensus of $0.12. Zscaler sees Q1 2022 revenue of $210-212 million, versus the consensus of $199.7 million. Zscaler sees FY2022 EPS of $0.52-$0.56, versus the consensus of $0.56. Zscaler sees FY2022 revenue of $940-950 million, versus the consensus of $905.8 million.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: IVERIC bio,Apellis Pharmaceuticals,Affirm and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: IVERIC bio,Apellis Pharmaceuticals,Affirm and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-10 07:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18924599><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nIVERIC bio (NASDAQ: ISEE) 47.9% HIGHER; gains following data from Apellis\nApellis Pharmaceuticals, Inc. (Nasdaq: APLS) 31.9% LOWER; reported top-line results from the Phase 3...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18924599\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"APLS":"Apellis Pharmaceuticals Inc.","ISEE":"IVERIC bio Inc","COOK":"Traeger Inc. (TGPX Holdings I LLC)","KPLT":"Katapult Holdings, Inc.","AFRM":"Affirm Holdings, Inc.","ZUMZ":"Zumiez Inc"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18924599","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2166479623","content_text":"After-Hours Stock Movers:\nIVERIC bio (NASDAQ: ISEE) 47.9% HIGHER; gains following data from Apellis\nApellis Pharmaceuticals, Inc. (Nasdaq: APLS) 31.9% LOWER; reported top-line results from the Phase 3 DERBY and OAKS studies evaluating intravitreal pegcetacoplan, an investigational targeted C3 therapy, in 1,258 adults with geographic atrophy (GA) secondary to age-related macular degeneration (AMD). OAKS met the primary endpoint for both monthly and every-other-month treatment with pegcetacoplan, demonstrating a significant reduction in GA lesion growth of 22% (p=0.0003) and 16% (p=0.0052), respectively, compared to pooled sham at 12 months. DERBY did not meet the primary endpoint of GA lesion growth, showing a reduction of 12% (p=0.0528) and 11% (p=0.0750) with monthly and every-other-month treatment, respectively, compared to pooled sham at 12 months.\nAffirm Holdings, Inc. (NASDAQ: AFRM) 20.8% HIGHER; reported Q4 EPS of ($0.48), $0.19 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $261.8 million versus the consensus estimate of $225.29 million. Affirm Holdings, Inc. sees Q1 2022 revenue of $240-250 million, versus the consensus of $233.9 million. Affirm Holdings, Inc. sees FY2022 revenue of $1.16-1.19 billion, versus the consensus of $1.17 billion.\nKatapult Holdings, Inc. (NASDAQ: KPLT) 12.2% HIGHER; gains on AFRM results.\nTraeger, Inc. (NYSE: COOK) 9.8% LOWER; reported Q2 EPS of ($0.05), versus $0.17 reported last year. Revenue for the quarter came in at $213 million, versus $153.2 million reported last year. Traeger, Inc. sees FY2021 revenue of $760-770 million. Adjusted EBITDA is expected to be between $103 million and $108 million\nCedar Realty Trust (NYSE: CDR) 8.5% HIGHER; announced that its Board of Directors has initiated a dual-track process to review the Company's strategic alternatives in order to maximize shareholder value. As part of this process, Cedar is exploring, among other alternatives, a potential sale or merger involving the entire Company, and alternatively the potential sale of its core grocery-anchored shopping center portfolio and its mixed-use redevelopment projects.\nAmerican Outdoor Brands (NASDAQ: AOUT) 5.9% HIGHER; reported Q1 EPS of $0.48, $0.08 better than the analyst estimate of $0.40. Revenue for the quarter came in at $60.8 million versus the consensus estimate of $57.35 million. American Outdoor Brands sees FY2022 EPS of $2.02-$2.26, versus the consensus of $2.21. American Outdoor Brands sees FY2022 revenue of $280-295 million, versus the consensus of $291 million.\nSumo Logic Inc. (NASDAQ: SUMO) 6.3% LOWER; reported Q2 EPS of ($0.11), $0.03 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $58.8 million versus the consensus estimate of $56.69 million. Sumo Logic Inc. sees Q3 2022 EPS of ($0.14), versus the consensus of ($0.15). Sumo Logic Inc. sees Q3 2022 revenue of $60.3-61.3 million, versus the consensus of $60.05 million. Sumo Logic Inc. sees FY2022 EPS of ($0.52)-($0.51), versus the consensus of ($0.56). Sumo Logic Inc. sees FY2022 revenue of $236.8-238.8 million, versus the consensus of $235.02 million\nCano Health (NYSE: CANO) 2.2% HIGHER; Cowen initiates coverage with an Outperform rating and a price target of $18.00.\nZumiez, Inc. (NASDAQ: ZUMZ) 5.3% LOWER; reported Q2 EPS of $0.94, $0.16 better than the analyst estimate of $0.78. Revenue for the quarter came in at $268.7 million versus the consensus estimate of $279.79 million.\nClover Health (NASDAQ: CLOV) 2.6% LOWER; Cowen analyst Gary Taylor initiates coverage with an Underperform rating and a price target of $7.00.\nEditas Medicine (NASDAQ: EDIT) 2.2% HIGHER; Oppenheimer upgraded from Perform to Outperform with a price target of $80.00 (from $42.00).\nTake-Two Interactive Software, Inc. (NASDAQ: TTWO) 2.5% LOWER; reiterated its outlook for its fiscal year 2022, ending March 31, 2022, which was originally provided on May 18, 2021 and reiterated on August 2, 2021. The Company’s wholly-owned label, Rockstar Games, has announced that the expanded and enhanced versions of Grand Theft Auto V and Grand Theft Auto Online for PlayStation 5 and Xbox Series X|S, which had been planned for release on November 11, 2021, are now planned to launch in March 2022 to allow additional time to further polish the final products.\nZscaler (NASDAQ: ZS) 2.4% HIGHER; reported Q4 EPS of $0.14, $0.05 better than the analyst estimate of $0.09. Revenue for the quarter came in at $197.1 million versus the consensus estimate of $186.82 million. Zscaler sees Q1 2022 EPS of $0.12, versus the consensus of $0.12. Zscaler sees Q1 2022 revenue of $210-212 million, versus the consensus of $199.7 million. Zscaler sees FY2022 EPS of $0.52-$0.56, versus the consensus of $0.56. Zscaler sees FY2022 revenue of $940-950 million, versus the consensus of $905.8 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":883697096,"gmtCreate":1631236633415,"gmtModify":1631890070855,"author":{"id":"4090418835913750","authorId":"4090418835913750","name":"jayfalcon","avatar":"https://static.tigerbbs.com/505029b8d840d52745c57c2cbf910d5c","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Interesting to know&nbsp;[哇塞]&nbsp;","listText":"Interesting to know&nbsp;[哇塞]&nbsp;","text":"Interesting to know [哇塞]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883697096","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":883604460,"gmtCreate":1631236135150,"gmtModify":1631890308087,"author":{"id":"3575500119873947","authorId":"3575500119873947","name":"winterflower","avatar":"https://static.tigerbbs.com/eeb88638c0d0fc78384e4f7a7514daaa","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Please like thank you","listText":"Please like thank you","text":"Please like thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883604460","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":883605316,"gmtCreate":1631236062035,"gmtModify":1632883761981,"author":{"id":"3582151718585472","authorId":"3582151718585472","name":"FrederickL","avatar":"https://static.tigerbbs.com/21ae0da315b7fd514ea9d30bfa0d125a","vip":1,"crmLevel":6,"crmLevelSwitch":0},"htmlText":"Wow. &nbsp; Like!","listText":"Wow. &nbsp; Like!","text":"Wow. Like!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/883605316","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5813058,"gmtCreate":1631236855167,"gmtModify":1634803831990,"authorId":3573684796405934,"author":{"id":3573684796405934,"authorId":3573684796405934,"name":"OinKeY","avatar":"https://static.tigerbbs.com/2f3d9ba6e0428bf38ab5a3329eec39be","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883605316,"type":1,"supId":0,"prevId":0,"content":"Yea man!!!","text":"Yea man!!!","html":"Yea man!!!"}],"langContent":"EN"},{"id":883875790,"gmtCreate":1631235490010,"gmtModify":1632883769102,"author":{"id":"3579600897400043","authorId":"3579600897400043","name":"Yuyu1988","avatar":"https://static.tigerbbs.com/34360b9887bbf562af82f13ffcd1affb","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Please like. Thanks.","listText":"Please like. Thanks.","text":"Please like. Thanks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/883875790","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5815699,"gmtCreate":1631247910155,"gmtModify":1631896136179,"authorId":3586564542180561,"author":{"id":3586564542180561,"authorId":3586564542180561,"name":"Chris82","avatar":"https://static.tigerbbs.com/bd197088a3b1cbc3c139d97a5851a381","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883875790,"type":1,"supId":0,"prevId":0,"content":"<u>Liked</u>","text":"<u>Liked</u>","html":"<u>Liked</u>"},{"id":5814001,"gmtCreate":1631239969543,"gmtModify":1631896136171,"authorId":3577664011514694,"author":{"id":3577664011514694,"authorId":3577664011514694,"name":"Nez","avatar":"https://static.tigerbbs.com/b32d6842fa474340581d116936497abb","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883875790,"type":1,"supId":0,"prevId":0,"content":"Done pls like and comment too thanks","text":"Done pls like and comment too thanks","html":"Done pls like and comment too thanks"}],"langContent":"EN"},{"id":883872471,"gmtCreate":1631235405993,"gmtModify":1631891282488,"author":{"id":"3568026014768326","authorId":"3568026014768326","name":"牛劲十足","avatar":"https://static.tigerbbs.com/8fbaf4c859c3c0e4072e34bf8ae302ba","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883872471","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":883847653,"gmtCreate":1631234993872,"gmtModify":1631885396407,"author":{"id":"3582366643541036","authorId":"3582366643541036","name":"Bonds","avatar":"https://static.tigerbbs.com/7927febac32666ca13d21b532f0ff6f6","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Up and up","listText":"Up and up","text":"Up and up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/883847653","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5812713,"gmtCreate":1631235398032,"gmtModify":1631885396407,"authorId":3568026014768326,"author":{"id":3568026014768326,"authorId":3568026014768326,"name":"牛劲十足","avatar":"https://static.tigerbbs.com/8fbaf4c859c3c0e4072e34bf8ae302ba","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883847653,"type":1,"supId":0,"prevId":0,"content":"YEs","text":"YEs","html":"YEs"}],"langContent":"EN"},{"id":883828399,"gmtCreate":1631233800811,"gmtModify":1631890057746,"author":{"id":"3582008315299880","authorId":"3582008315299880","name":"KLCC","avatar":"https://static.tigerbbs.com/08be1d09de6993c135144551b2568831","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Liked","listText":"Liked","text":"Liked","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/883828399","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5813899,"gmtCreate":1631239640969,"gmtModify":1634803758464,"authorId":3581905357038973,"author":{"id":3581905357038973,"authorId":3581905357038973,"name":"Irenelim85","avatar":"https://static.tigerbbs.com/90d775f1edd315221f691822d8f5dc28","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883828399,"type":1,"supId":0,"prevId":0,"content":"🦾","text":"🦾","html":"🦾"}],"langContent":"EN"},{"id":883866314,"gmtCreate":1631233267038,"gmtModify":1631890065823,"author":{"id":"3575588910593021","authorId":"3575588910593021","name":"Goodmeng","avatar":"https://static.tigerbbs.com/96dc060537e6112d51026eaa7dd4db92","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883866314","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":883883368,"gmtCreate":1631232681254,"gmtModify":1631883869596,"author":{"id":"4088779006345160","authorId":"4088779006345160","name":"Desoupie","avatar":"https://static.tigerbbs.com/61605302726ca838436e74d61cb437ae","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like pls [Bless]&nbsp;","listText":"Like pls [Bless]&nbsp;","text":"Like pls [Bless]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/883883368","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5812343,"gmtCreate":1631234045736,"gmtModify":1631883869598,"authorId":3580363111370038,"author":{"id":3580363111370038,"authorId":3580363111370038,"name":"Kinokinok","avatar":"https://static.tigerbbs.com/0f1aab7b42bc118820a5c63211782a7c","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883883368,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"}],"langContent":"EN"},{"id":883889581,"gmtCreate":1631232651943,"gmtModify":1631889396391,"author":{"id":"3568944508199908","authorId":"3568944508199908","name":"saral","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0},"htmlText":"Like pls thks.&nbsp;","listText":"Like pls thks.&nbsp;","text":"Like pls thks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883889581","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":249,"commentSize":33,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}